NEWS-SaiAo Biotech | CAR-T Cell Therapy & Biopharmaceutical

EN

EN
عربي

Home / NEWS

Patient Success Stories

Literature Downloads

81eeb918-2dd5-40dd-9bb0-a225e41e6305

High Efficacy and Safety of Low Dose CD19-directed CAR-T-cell Therapy in 51 Refractory or Relapsed B Acute Lymphoblastic Leukemia Patients

Leukemia 2017: Large-cohort study of low-dose CD19 CAR-T therapy demonstrating high CR rates with reduced toxicity in 51 r/r B-ALL patients, supporting lower dosing as a viable strategy.

09 August 2025

Paul, Russian, follicular lymphoma (FL)

A Russian patient with follicular lymphoma experienced a relapse but achieved complete remission (CR) following CAR-T therapy

View More >>
27 September 2026

A Multi-Targeting Chimeric Antigen Receptor-T Cell Platform to Overcome Antigen Heterogeneity in the Treatment of Non-Small Cell Lung Cancer

View More >>
06 May 2025

Artem’s Journey: Fighting Relapsed B-ALL with Sequential CAR-T Therapy #GoBroad #leukemia #CARTtherapy #immunotherapy

Artem’s Journey: Fighting Relapsed B-ALL with Sequential CAR-T Therapy #GoBroad #leukemia #CARTtherapy #immunotherapy

View More >>
10 August 2025

Pavel’s Journey: A Ballet Dancer’s Fight Against Follicular Lymphoma with CAR-T Therapy

Pavel’s Journey: A Ballet Dancer’s Fight Against Follicular Lymphoma with CAR-T Therapy

View More >>
12 September 2025

Tiantian, Chinese, Burkitt lymphoma

In 2017, six-year-old Tian Tian was diagnosed with Burkitt lymphoma. Despite undergoing several rounds of high-dose chemotherapy as the first line of treatment, he did not reach complete remission. He then received second-line chemotherapy, but the tumor continued to grow.

View More >>

1 2 3 4 5